CDK4/6 is crucial for the G1- to S-phase transition and abnormalities in CDK4/6 and the NF1 (a negative regulator of RAS activity) gene may contribute to neuroblastoma and malignant peripheral nerve sheath tumors. The gene discussed is CDK4; the disease is malignant peripheral nerve sheath tumor.